Eulexin, containing 250 mg of flutamide as the active ingredient, is a trusted medication for the management of prostate cancer in men. It operates as an anti-androgen, assisting in the reduction of male hormones that contribute to cancer growth. Eulexin is produced by various pharmaceutical manufacturers and is available under additional brand names like Cytomid, Flutacris, and Flutamed.